publication venue for
- Metastasis suppressor NME1 in exosomes or liposomes conveys motility and migration inhibition in breast cancer model systems. 2022
- Current challenges in metastasis research and future innovation for clinical translation. 2022
- Defining the landscape of metabolic dysregulations in cancer metastasis. 2021
- Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases.. 37. 2020
- Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases.. 31. 2013
- Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis.. 30. 2012
- Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain.. 28. 2011
- Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways.. 28. 2011
- Mena invasive (Mena(INV)) and Mena11a isoforms play distinct roles in breast cancer cell cohesion and association with TMEM.. 28. 2011
- Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer.. 27. 2010
- Immunoblot analysis of c-Met expression in human colorectal cancer: overexpression is associated with advanced stage cancer.. 21. 2004
- Thymosin beta15 expression in tumor cell lines with varying metastatic potential.. 16. 1998
- Clonal dominance detected in metastases but not primary tumors of retrovirally marked human breast carcinoma injected into nude mice.. 12. 1994
- Cancer cell metabolic plasticity in migration and metastasis. 2021
- Cancer microenvironment and genomics: evolution in process. 2021
- Breast cancer disparities in outcomes; unmasking biological determinants associated with racial and genetic diversity. 2021
- Meeting the biologic challenge of colorectal metastases. 2012